Meridian Bioscience, Inc. VIVO is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Â Earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook.For Meridian Bioscience, there has been strong agreement among the covering analysts in raising earnings estimates, which has helped push consensus estimates considerably higher for the next quarter and full year. The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this diagnostic test maker, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
Steel Dynamics, Inc. STLD is among the leading steel producers and metal recyclers in the United States.Â Steel Dynamics expects adjusted earnings per share for the fourth quarter to be higher on a sequential basis. Earnings estimates for Steel Dynamics for the fourth quarter have been going up over a month. The company is expected to gain from its strategic acquisitions as well as strong liquidity and efforts to expand capacity. The acquisitions of Heartland and United Steel Supply have boosted Steel Dynamics’ shipping capabilities. Moreover, the buyout of Zimmer will support its raw material procurement strategy at its new Texas flat roll steel mill. The company is also expected to gain from its investments to beef up capacity and upgrade facilities. Steel Dynamics is also executing a number of projects that should add to capacity and boost profitability.Â The company has beat on EPS four quarters in a row and will officially report Q4 earnings in late January.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by referendums and legislation, this industry is expected to blast from an already robust $17.7 billion in 2019 to a staggering $73.6 billion by 2027. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot stocks we’re targeting >>